Companion: Sensor-based Two-way Communication for Physical Activity in Older Adults
An Integrated Two-Way Communication and Near-Real-Time Sensing System to Detect and Modify Daily Inactivity Among Adults Over Age 60
2 other identifiers
interventional
51
1 country
1
Brief Summary
This pilot study is a small sample (N=46) 16-week clinical trial with a follow-up after 24-weeks among sedentary adults \>60 y with a BMI \>25 kg/m2 to tests the impact of a hybrid artificial intelligence behavior change system (Companion) on physical activity. Participants will be randomized to a control and intervention group. All participants will engage in a proven supervised exercise program from week 1 to 16. Only the intervention group will receive Companion from week 1 to 16.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2021
CompletedFirst Submitted
Initial submission to the registry
March 23, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2022
CompletedResults Posted
Study results publicly available
July 3, 2024
CompletedJuly 3, 2024
June 1, 2024
1.6 years
March 23, 2021
March 21, 2024
June 29, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Physical Activity Hours Per Day Measured Using a Body-worn Accelerometer at Baseline
Total time spent being active will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.
Baseline
Physical Activity Hours Per Day Measured Using a Body-worn Accelerometer After 4 Months
Total time spent being active will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.
4 months
Physical Activity Hours Per Day Measured Using a Body-worn Accelerometer After 6 Months
Total time spent being active will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.
6 months
Sedentary Behavior Hours Per Day Measured Using a Body-worn Accelerometer at Baseline
Total time spent sedentary will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.
Baseline
Sedentary Behavior Hours Per Day Measured Using a Body-worn Accelerometer After 4 Months
Total time spent sedentary will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.
4 months
Sedentary Behavior Hours Per Day Measured Using a Body-worn Accelerometer After 6 Months
Total time spent sedentary will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.
6 months
Other Outcomes (18)
Percent Body Fat Measured Via Bioelectrical Impedance at Baseline
Baseline
Percent Body Fat Measured Via Bioelectrical Impedance After 4 Months
4 months
Percent Body Fat Measured Via Bioelectrical Impedance After 6 Months
6 months
- +15 more other outcomes
Study Arms (2)
Control
NO INTERVENTIONControl group will engage in a 16-week supervised exercise program and then be followed-up after 24 weeks
Treatment
EXPERIMENTALTreatment group will engage in a 16-week supervised exercise program and then be followed-up after 24 weeks. In addition, the Companion will be deployed in the treatment group only.
Interventions
Companion integrates wearable sensing with the smartphone to develop a behavior-aware, virtual system that uses a "human-in-the-loop" approach to enable meaningful two-way communication. Companion builds rich models of typical behavior using sensors and context sensitive ecological momentary assessment to deliver intervention components and behavior change strategies using socially engaging, contextually salient, and tailored text-message conversations in near-real-time.
Eligibility Criteria
You may qualify if:
- Age 60 years and above- This intervention study focusses on this population demographic.
- Participants have a body mass index greater than 25 kg/m2- This threshold for BMI is used to classify an adult as overweight or obese
- No conditions preventing participation in physical activity lasting 10 to 30 min- Such conditions will limit prescription of physical activity/exercise components of the training program and that promoted using Companion.
- Have a smart phone- The absence of a smart phone will limit the ability of remote communication with the study participant using Companion.
You may not qualify if:
- Engage in structured physical activity for more than 2 days/week lasting 30 min/session- Physically active participants will not be representative of typical adults \>60 y. Being active prior to study participation may mask the effects of the intervention.
- Regularly use any assistive device for walking- Use of an assistive device would limit the ability to engage in prescribed physical activity. Future work can be tailored for sub-groups in the demographic being studied.
- Likely to alter medications pertaining to cardiovascular or metabolic health- Altering medications during the study will influence change in selected outcome measures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northeastern Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Northeastern Univeristy
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Dinesh John
- Organization
- Northeastern University
Study Officials
- PRINCIPAL INVESTIGATOR
Dinesh John, PhD
Northeastern University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 23, 2021
First Posted
April 1, 2021
Study Start
March 16, 2021
Primary Completion
November 2, 2022
Study Completion
December 13, 2022
Last Updated
July 3, 2024
Results First Posted
July 3, 2024
Record last verified: 2024-06